NUVL
Nuvalent, Inc.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells since Jul 15. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 37 added (14 new), 43 trimmed or exited. Largest new: Pentwater Capital Management $145.1M, Balyasny Asset Management $128.1M.
- EstimatesFLAT
Current-quarter EPS estimate −$1.372 → −$1.378 over 90 days. 0 up, 2 down in 30 days.
- Short sellersCOVERING
Short interest −75.4% to 715.8K shares. 1.0 days to cover, ≈0.9% of shares.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| FIL Ltd | DOUBLED | $363.9M |
| GOLDMAN SACHS GROUP INC | DOUBLED | $202.6M |
| FMR LLC | NEAR_EXIT | $175.1M |
| BARCLAYS PLC | DOUBLED | $156.6M |
| RA CAPITAL MANAGEMENT, L.P. | TRIM | $153.9M |
| Pentwater Capital Management LP | NEW | $145.1M |
| BALYASNY ASSET MANAGEMENT L.P. | NEW | $128.1M |
| BANK OF AMERICA CORP /DE/ | DOUBLED | $108.3M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Jun 2026| Date | Firm | Rating |
|---|---|---|
| Jun 24, 2026 | Bernstein DOWNGRADE | Market Perform |
| Jun 10, 2026 | Truist Securities DOWNGRADE | Hold |
| Jun 10, 2026 | TD Cowen DOWNGRADE | Hold |
| Jun 10, 2026 | Barclays DOWNGRADE | Equal-Weight |
| Jun 10, 2026 | Wedbush DOWNGRADE | Neutral |
| Jun 10, 2026 | UBS DOWNGRADE | Neutral |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Srivastava Sapna Director Jul 15, 2026 | TENDER | $638.1K |
Srivastava Sapna Director Jul 15, 2026 | TO ISSUER | 3,444 sh |
Srivastava Sapna Director Jul 15, 2026 | TO ISSUER | 68,500 sh |
Srivastava Sapna Director Jul 15, 2026 | TO ISSUER | 20,000 sh |
Srivastava Sapna Director Jul 15, 2026 | TO ISSUER | 15,000 sh |
Srivastava Sapna Director Jul 15, 2026 | TO ISSUER | 3,789 sh |
Srivastava Sapna Director Jul 15, 2026 | TO ISSUER | 4,147 sh |
Balcom Alexandra Chief Financial Officer Jul 15, 2026 | AWARD | 14,350 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$1.38 | -$1.48–-$1.13 | -0.7% | $0.00 |
| Next Q | -$1.40 | -$1.57–-$1.21 | -1.0% | $1.4M |
| Current FY | -$5.50 | -$6.37–-$4.69 | -0.5% | $10.7M |
| Next FY | -$4.02 | -$5.49–-$2.84 | +2.8% | $181.0M |
Short side
FINRA· Jul 15, 2026| Jul 14, 2026 | Deletion | Resumed |
SecBot reports
18 filings · 4 bullish · 4 bearish · 10 neutral- NEUTRAL 15-12GJul 27, 2026
Nuvalent filed a Form 15-12G to terminate its SEC registration under Section 12(g) following the…
This filing is a procedural step following the completed GSK acquisition. No further trading action is warranted as the stock has already been delisted and cashed out at $124.00 per share.
- NEUTRAL 25-NSEJul 15, 2026
Nasdaq filed a 25-NSE notification to delist Nuvalent, Inc. shares following the completion of GSK…
The delisting is a formality following the completed acquisition. Shareholders who have not yet tendered shares should receive the $124.00 cash consideration. No further trading on Nasdaq is expected.
- BULLISH 8-KJul 15, 2026
GSK plc has completed its acquisition of Nuvalent, Inc. via a tender offer and merger. The tender…
Remaining shareholders who did not tender should promptly submit their shares to receive the $124.00 per share merger consideration. The stock will be delisted and deregistered, eliminating any…
- NEUTRAL CLUSTERJul 8, 2026
Three top executives at Nuvalent (CEO, CFO, CDO) sold a combined $7.97M in open-market sales over…
The CEO's sale is fully explained by a cashless derivative exercise, not a conviction sale. CFO and CDO sales are modest relative to market cap. No material signal for traders. Monitor upcoming…
All NUVL filing & press-release reports (18)
- 15-12G reportJul 27, 2026
- 25-NSE reportJul 15, 2026
- 8-K reportJul 15, 2026
- CLUSTER reportJul 8, 2026
- CLUSTER reportJul 6, 2026
- CLUSTER reportJun 11, 2026
- CLUSTER reportJun 10, 2026
- 8-K reportJun 9, 2026
- 8-K reportMay 7, 2026
- CLUSTER reportApr 29, 2026
- CLUSTER reportApr 6, 2026
- CLUSTER reportMar 30, 2026
- 8-K reportApr 7, 2026
- CLUSTER reportMar 26, 2026
- CLUSTER reportMar 25, 2026
- CLUSTER reportMar 25, 2026
- CLUSTER reportMar 6, 2026
- 8-K reportFeb 26, 2026